文章摘要
王微,黄锡通,王丹红,黄丹阳,陈媛媛.莫沙必利治疗夜间消化不良的效果和安全性[J].中国临床保健杂志,2020,23(1):130-132.
莫沙必利治疗夜间消化不良的效果和安全性
Effect and safety of mosapride on night dyspepsia
投稿时间:2019-09-02  
DOI:10.3969/J.issn.1672-6790.2020.01.030
中文关键词: 消化不良  莫沙必利  多潘立酮  治疗结果
英文关键词: Dyspepsia  Mosapride  Domperidone  Treatment outcome
基金项目:浙江省医药卫生科技计划项目(2019KY794)
作者单位E-mail
王微 浙江玉环市人民医院,消化内科,317600 verawong09@163.com 
黄锡通 浙江玉环市人民医院急诊内科,317600  
王丹红 浙江玉环市人民医院,消化内科,317600  
黄丹阳 浙江玉环市人民医院,消化内科,317600  
陈媛媛 浙江玉环市人民医院,消化内科,317600  
摘要点击次数: 4869
全文下载次数: 5597
中文摘要:
      目的 探讨莫沙必利治疗夜间消化不良的效果和安全性。方法 选取82例夜间消化不良患者,根据入院先后顺序按照随机数表法将其分为A组与B组,每组41例,A组予以多潘立酮治疗,B组予以莫沙必利治疗,对比两组患者的临床疗效、胃排空率、近端胃容积、胃动力指标(血浆胃动素、胃泌素-17、乙酰胆碱酯酶)以及不良反应情况(腹泻、过敏、头痛、头晕)。结果 B组临床疗效的总有效率(92.7%)高于A组(73.2%),P<0.05;两组治疗后的胃排空率均高于本组治疗前,且B组高于A组,P<0.05;两组治疗后的近端胃容积均小于本组治疗前,且B组小于A组,P<0.05;B组治疗后的胃动素、胃泌素-17、乙酰胆碱酯酶水平均高于A组,P<0.05;B组的不良反应发生率(9.8%)低于A组(26.8%),P<0.05。结论 莫沙必利对夜间消化不良患者的治疗效果显著,可明显提高胃排空率,减小近端胃容积,改善胃动力指标,不良反应少。
英文摘要:
      Objective To investigate the efficacy and safety of mosapride in the treatment of night dyspepsia .Methods A total of 82 patients with night dyspepsia were divided into group A and group B according to the order of admission.And 41 patients in each group were treated with morpholine in group A and mosapride in group B.The clinical efficacy,gastric emptying rate and proximal gastric volume,gastric motility index (plasma motilin,gastrin-17,acetylcholinesterase) and adverse reactions (diarrhea,allergy,headache,dizziness) of the two groups were compared.Results The total effective rate of group B (92.7%) was higher than that of group A (73.2%),P<0.05;the gastric emptying rate after treatment in both groups was higher than that of previous treatment,and group B was higher than that in group A (P<0.05).The proximal gastric volume after treatment in both groups was less than that of previous treatment,and group B was smaller than that in group A (P<0.05).The levels of motilin,gastrin-17 and acetylcholinesterase after treatment in group B were higher than those in group A (P<0.05).The incidence of adverse reactions in group B (9.8%) was lower than that in group A (26.8%),P<0.05.Conclusion Mosapride has remarkable therapeutic effect on patients with night dyspepsia.It can significantly increase gastric emptying rate,reduce proximal gastric volume,improve gastric motility index with less adverse reactions and high safety.
查看全文     
关闭
分享按钮